From: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
First author | Year | Duration (months) | Histology | Stage | Patient number | Quality score | Detection | Platform |
---|---|---|---|---|---|---|---|---|
Yuan A [40] | 2000 | 28 | NSCLC | I–III | 58 | 8 | Microarray | Perkin-Elmer Applied Biosystems |
Tang H [41] | 2013 | 120 | NSCLC | I–III | 176 | 9 | Microarray | IlluminaHumanWG-6v3.0 |
Raponi M [42] | 2006 | 144 | SQC | I–III | 129 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Tomida S [43] | 2009 | 109.8 | ADC | I–III | 117 | 9 | Microarray | AgilentWholeHumanGenomeMicroarray 4x44K G4112F |
Botling J [44] | 2013 | 120 | NSCLC | I–IV | 196 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Beer DG [45] | 2002 | 110.6 | ADC | I–III | 86 | 8 | Microarray | AffymetrixHumanFullLength HuGeneFL |
Landi MT [46] | 2008 | NR | ADC | I–IV | 74 | 9 | Microarray | AffymetrixHgu133a |
Lu T [47] | 2010 | NR | ADC | I–IV | 60 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Selamat SA [48] | 2012 | NR | ADC | I–III | 58 | 8 | Microarray | IlluminaHumanWG-6v3.0 expression |
Meyerson M [49] | 2015 | NR | SQC | I–IV | 135 | 8 | Microarray | AffymetrixHgu133a |